A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects

Clinical trial NCT02342652 · COMPLETED

Trial details

NCT number: NCT02342652
Sponsor: ASLAN Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Elderly Subjects (Age ≥55 Years)

Start date: 2014-10-01
Primary completion: 2015-03-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.